AU2444695A - Use of intravenously administered iron in the therapy of tumoral and infectious diseases - Google Patents

Use of intravenously administered iron in the therapy of tumoral and infectious diseases

Info

Publication number
AU2444695A
AU2444695A AU24446/95A AU2444695A AU2444695A AU 2444695 A AU2444695 A AU 2444695A AU 24446/95 A AU24446/95 A AU 24446/95A AU 2444695 A AU2444695 A AU 2444695A AU 2444695 A AU2444695 A AU 2444695A
Authority
AU
Australia
Prior art keywords
tumoral
therapy
infectious diseases
intravenously administered
administered iron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24446/95A
Inventor
Freiherr von Nagell Helmut Rau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmut Freiherr Von Nagell Rau
Original Assignee
RAU HELMUT FREIHERR VON NAGELL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RAU HELMUT FREIHERR VON NAGELL filed Critical RAU HELMUT FREIHERR VON NAGELL
Publication of AU2444695A publication Critical patent/AU2444695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The use of intravenously administered iron in the therapy of tumoral diseases and/or infectious diseases is disclosed. It has been discovered that the intravenous administration of iron leads to surprising cures of tumoral diseases, as well as infectious diseases.
AU24446/95A 1994-06-01 1995-05-17 Use of intravenously administered iron in the therapy of tumoral and infectious diseases Abandoned AU2444695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4419256 1994-06-01
DE4419256A DE4419256A1 (en) 1994-06-01 1994-06-01 Intravenous admin of iron
PCT/DE1995/000665 WO1995032711A1 (en) 1994-06-01 1995-05-17 Use of intravenously administered iron in the therapy of tumoral and infectious diseases

Publications (1)

Publication Number Publication Date
AU2444695A true AU2444695A (en) 1995-12-21

Family

ID=6519591

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24446/95A Abandoned AU2444695A (en) 1994-06-01 1995-05-17 Use of intravenously administered iron in the therapy of tumoral and infectious diseases

Country Status (8)

Country Link
EP (1) EP0788355B1 (en)
AT (1) ATE184790T1 (en)
AU (1) AU2444695A (en)
DE (2) DE4419256A1 (en)
DK (1) DK0788355T3 (en)
ES (1) ES2137513T3 (en)
GR (1) GR3031505T3 (en)
WO (1) WO1995032711A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19600744A1 (en) * 1996-01-11 1997-07-17 Werner Alois Prof Dipl Kaiser Magnetic substance for local hyperthermic treatment of mainly small tumors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2527158A1 (en) * 1975-06-18 1976-12-23 Herz Eberhard MEDICINAL PRODUCTS FOR THE TREATMENT OF INFECTIOUS DISEASES AND INFLAMMATION IN HUMAN AND VETERINAL MEDICINE THAT CANNOT BE DETECTED BY MICROORGANISMS
CH625125A5 (en) * 1975-09-26 1981-09-15 Biokema Sa Method for manufacturing a stable injectable solution of immunoglobulins and organic iron, and product obtained by this method
JPS6039681B2 (en) * 1976-01-01 1985-09-07 日本臓器製薬株式会社 Dextrin-citric acid-ferric polynuclear complex and parenteral iron preparation containing the complex
GB1546177A (en) * 1976-11-19 1979-05-16 Biokema Sa Process for the preparation of a stable injectable solution
GB2024007B (en) * 1978-06-30 1983-04-27 Gordon R T Cancer-treating composition containing inductively heatable particles
EP0227593A1 (en) * 1985-11-25 1987-07-01 The Hospital For Sick Children Use of chelating agents
GB8607137D0 (en) * 1986-03-21 1986-04-30 Efamol Ltd Compositions
JP2648329B2 (en) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー Pharmaceutical composition for preventing or treating AIDS
DE3842143A1 (en) * 1988-12-15 1990-06-21 Nitsche Dietrich USE OF TRANSFERRIN FOR ENDOTOXIN NEUTRALIZATION
WO1990007322A1 (en) * 1988-12-19 1990-07-12 David Gordon Diagnosis and treatment of viral effects
DE4117782C2 (en) * 1991-05-28 1997-07-17 Diagnostikforschung Inst Nanocrystalline magnetic iron oxide particles, processes for their production and diagnostic and / or therapeutic agents
FR2677885B1 (en) * 1991-06-20 1994-08-26 Rocher Labo Biolog Vegetale Y PLANT-BASED COMPOSITION FOR USE IN COSMETOLOGY, HYGIENE OR PHARMACY AND PROCESS FOR PREPARING THE SAME.
JP3100005B2 (en) * 1992-07-28 2000-10-16 雪印乳業株式会社 Human immunodeficiency virus infection / growth inhibitor

Also Published As

Publication number Publication date
GR3031505T3 (en) 2000-01-31
EP0788355B1 (en) 1999-09-22
WO1995032711A1 (en) 1995-12-07
EP0788355A1 (en) 1997-08-13
ATE184790T1 (en) 1999-10-15
ES2137513T3 (en) 1999-12-16
DK0788355T3 (en) 2000-03-20
DE4419256A1 (en) 1995-12-07
DE59506911D1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
TW250435B (en)
TW286283B (en)
TW371628B (en) Composition for treating condyloma acuminata
HK1030157A1 (en) Use of consensus interferon and compositions comprising consensus interferon.
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
BG106171A (en) Compositions and uses of et743 for treating cancer
MY125984A (en) Pharmaceutical solutions of levosimendan.
PT1007055E (en) UTILIZATION OF AMIFOSTINE
GB9425730D0 (en) Compounds
NO943288L (en) Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease
MD990258A (en) Method of treatment of the acute viral hepatitis B
NZ533309A (en) Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
AU2444695A (en) Use of intravenously administered iron in the therapy of tumoral and infectious diseases
AU2229997A (en) Pharmaceutical compositions comprising natural human alpha-interferon
WO1998036758A3 (en) Therapeutic agents containing oxygen anion radicals and the use thereof in the treatment of parkinson's disease
TR200000728T2 (en) The use of IFN-alpha and amantadine in the treatment of chronic hepatitis C.
UA10219A (en) Method for treatment of pulmonary tuberculosis
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors
UA10259A (en) Neuropolyosm, antiedematous drug
RU94023697A (en) Method for treating early age children possessing infectious toxicosis